Prosecution Insights
Last updated: April 19, 2026

Harbinger Health Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18514333 RARE NUCLEIC ACID DETECTION WOOLWINE, SAMUEL C 1681 Non-Final OA Nov 20, 2023
18212371 SELECTIVE ENRICHMENT GOLDBERG, JEANINE ANNE 1682 Non-Final OA Jun 21, 2023
18128698 RARE NUCLEIC ACID DETECTION WOOLWINE, SAMUEL C 1681 Non-Final OA Mar 30, 2023
17498290 ISOLATION OF TARGET NUCLEIC ACIDS MUMMERT, STEPHANIE KANE 1681 Non-Final OA Oct 11, 2021

Managing Harbinger Health Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month